Your browser doesn't support javascript.
loading
Assessing cardiac safety in oncology drug development.
Seltzer, Jonathan H; Gintant, Gary; Amiri-Kordestani, Laleh; Singer, Jack; Koplowitz, Luana Pesco; Moslehi, Javid J; Barac, Ana; Yu, Anthony F.
Affiliation
  • Seltzer JH; ACI Clinical, Bala Cynwyd, PA. Electronic address: jseltzer@aciclinical.com.
  • Gintant G; Abbvie, North Chicago, IL.
  • Amiri-Kordestani L; FDA, Silver Spring, MD.
  • Singer J; Washington State University, CTI Biopharma, Seattle WA.
  • Koplowitz LP; DUCK FLATS Pharma, Elbridge, NY.
  • Moslehi JJ; Vanderbilt University Medical Center, Nashville TN.
  • Barac A; Georgetown University/Medstar Health, Washington DC.
  • Yu AF; Memorial Sloan Kettering, New York NY.
Am Heart J ; 214: 125-133, 2019 08.
Article in En | MEDLINE | ID: mdl-31202099
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Drug Development / Heart / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Am Heart J Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Drug Development / Heart / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Am Heart J Year: 2019 Type: Article